| Name | Title | Contact Details |
|---|
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
Simplex was founded in April 2007 to provide home delivery of medical supplies to help patients with diabetes.
For over 20 years, Progressive Medical has offered cost management services to clients, quality care to injured parties and programs to the workers' compensation and auto no-fault insurance industries.
Flare Capital Partners invests and specializes exclusively in the healthcare technology sector. Working side-by-side, Flare Capital parlays strengths in business and medicine into action that supports entrepreneurs who provide innovative solutions and strive to be market leaders.
NAMSA North American Science Associates, Inc. is a Northwood, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.